Study Could Widen Market For Cholesterol Treatments
By RON WINSLOW
Two decades after the first cholesterol-lowering drug known as a statin hit the market, a major new study is poised to reshape the landscape for the world's best-selling class of medicines.
*http://online.wsj.com/article/SB122567849033392265.html